December 18, 2019 / 10:24 PM / a month ago

CORRECTED-BRIEF-ImmunoPrecise Announces Qtrly Net Loss Of $1.4 Mln (Dec. 17)

(Corrects to remove extraneous word ‘record’ from headline)

Dec 17 (Reuters) - Immunoprecise Antibodies Ltd:

* IMMUNOPRECISE ANNOUNCES RECORD QUARTERLY REVENUE AND SIGNIFICANTLY EXPANDS GROSS MARGINS

* IMMUNOPRECISE ANTIBODIES LTD - QTRLY REVENUES OF $3.2 MILLION VERSUS $2.7 MILLION

* IMMUNOPRECISE ANTIBODIES LTD - QTRLY NET LOSS OF $1.4 MILLION

* IMMUNOPRECISE ANTIBODIES LTD - REVENUE OUTLOOK IS POSITIVE FOR Q3 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below